What to Look For From MRNA
Key points to remember Analysts estimate EPS at $4.55 versus $6.46 in Q2 2021. Revenues are expected to grow at a slower pace as the global pandemic subsides. On July 29, Moderna received an order from the US government for 66 million doses of its vaccine, with an option to purchase an additional 234 million…